Recent Security Class Actions

Geron Corporation Common Stock (NASDAQ: GERN)

48 Days left to seek lead plaintiff status.

Company Name:Geron Corporation Common Stock
Stock Symbol:NASDAQ: GERN
Class Period Start:02/28/2024
Class Period End (inclusive):02/25/2025
Filing Deadline:05/12/2025

According to the complaint, defendants provided investors with material information concerning defendants' expectations for the launch and growth potential of Rytelo (imetelstat). Defendants' statements included, among other things, confidence in Geron's ability to capitalize on the purportedly significant unmet need for the drug and to execute on its commercial plan to target first-line ESA ineligible patients, while continually minimizing the risks associated with the burden of the weekly monitoring requirement for Rytelo and the impacts of seasonality and existing competition on the drug's sales.

Geron Corporation Common Stock (NASDAQ: GERN) Claim Form

Name(Required)
Address
This field is for validation purposes and should be left unchanged.